Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies

Main Article Content

Kim Papp
Kristian Reich
Andrew Blauvelt
Diamant Thaci
Rodney Sinclair
Stephen K Tyring
Nicole Cichanowitz
Stuart Green
Qing Li
Carmen La Rosa


psoriasis, tildrakizumab, clinical trial


Abstract not available.


Study supported by Merck & Co., Inc.